STING agonists also show potential in influenza (Luo et al., 2019), BCG (Erik et al., 2018), and HIV vaccines (Chattopadhyay and Hu, 2020) by promoting dendritic cell (DC) activation, increasing antibody production, and enhancing T-cell responses. The gene discussed is STING1; the disease is influenza.